+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Invirase"

HIV Drugs and Injectables Market Report 2024-2034 - Product Thumbnail Image

HIV Drugs and Injectables Market Report 2024-2034

  • Report
  • July 2024
  • 288 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Invirase is a brand of antiretroviral drug used to treat HIV/AIDS. It is a protease inhibitor, which works by blocking the action of the HIV protease enzyme, preventing the virus from replicating. Invirase is used in combination with other antiretroviral drugs to treat HIV infection. It is available in tablet and oral suspension form. Invirase is one of several antiretroviral drugs used to treat HIV/AIDS. Other drugs in this class include Atripla, Combivir, and Truvada. These drugs are used in combination with other antiretroviral drugs to treat HIV infection. The Invirase market is highly competitive, with several companies offering similar products. Companies in the market include Roche, Gilead Sciences, Merck, and Bristol-Myers Squibb. These companies are all major players in the HIV/AIDS drug market, and they offer a range of products to treat HIV infection. Show Less Read more